How long does 3-FMA last?

The total duration of 3-FMA via oral is 3 hours to 7 hours. Onset typically occurs within 20 minutes to 1 hour. Peak effects last 2 hours to 4 hours.

3-FMA — SubstanceWiki

3-FMA

Amphetamine, Substituted amphetamines · Entactogen, Stimulants

7 dangerous interactions — combining 3-FMA with certain substances may be life-threatening.

See all

Entactogen, Stimulants(Amphetamine, Substituted amphetamines)

Quick Dosage

oral20–35 mg (common)

Total duration (oral)3hr–7hr

View full details

3-Fluoromethamphetamine (3-FMA) is a fluorinated analog of methamphetamine in which a fluorine atom occupies the 3-position (meta) of the phenyl ring. It belongs to both the Stimulants and Entactogen psychoactive classes, reflecting a dual pharmacological profile that combines the catecholaminergic activity characteristic of methamphetamine with a serotonergic component that produces mild empathogenic and mood-enhancing effects.

3-FMA's effect profile positions it between 2-FMA (a relatively pure dopaminergic/noradrenergic stimulant) and 4-FA (which produces stronger MDMA-like entactogenic effects). At moderate doses, community reports describe a combination of sustained focus, energy, and social enhancement — a stimulant foundation overlaid with emotional warmth and openness that falls short of the full entactogenic immersion of 4-FA but exceeds the social coldness of 2-FMA. This hybrid profile makes it appealing for both work-related use and social recreation.

Despite its dual-class designation, 3-FMA carries all the risks associated with releasing agents acting on serotonin: potential neurotoxicity with heavy use, more pronounced comedowns than purely dopaminergic stimulants, and heightened risk of serotonin syndrome in drug combinations. Formal human pharmacological and toxicological data do not exist, and all risk characterization relies on structural analogy and community experience.

How It Feels

The onset of 3-FMA arrives within thirty to fifty minutes as a balanced upwelling of energy and warmth. There is a building alertness in the mind and a subtle expansion of emotional openness, the two qualities rising together in a blend that gives the substance its distinctive character. Heart rate increases gently, a mild warmth spreads through the chest, and there is a growing sense that both tasks and people are more interesting than they were an hour ago.

As the effects develop over the next hour, 3-FMA reveals itself as a genuine hybrid. The stimulant dimension provides clean, sustained focus and physical energy. The empathogenic dimension softens the clinical edge that pure stimulants can carry, adding a warmth to social interactions and a richness to sensory experience that would be absent from a purely dopaminergic compound. Music sounds notably better. Conversations feel engaging and meaningful. There is enough cognitive enhancement to be productive and enough emotional warmth to be genuinely sociable, a combination that many find uniquely versatile.

At the peak, typically two to three hours in, the balance holds steady. The stimulation is firm but never jittery. The empathogenic warmth is present but never overwhelming. The jaw clenches with moderate persistence, appetite is suppressed, and the body runs slightly warm. Mood is elevated into a zone of confident, sociable optimism. Physical movement feels good, and there is enough energy for sustained activity, whether that means dancing, working, or extended conversation. The headspace remains clear and functional throughout, with none of the confusion or cognitive impairment that can accompany more serotonergically heavy compounds.

The duration of 3-FMA is notable, typically six to eight hours of primary effects with a gradual taper rather than a sudden drop. As the experience winds down, the empathogenic component fades first, leaving behind a residual stimulation that eventually gives way to mild fatigue. The comedown is generally smooth, less punishing than strongly serotonergic substances and less abrupt than shorter-acting stimulants. Sleep may be delayed but arrives without major difficulty. The following day is typically unremarkable, with at most a slight tiredness that resolves by afternoon.

Detection Methods

Standard Drug Panel Inclusion

3-FMA (3-Fluoromethamphetamine) is a fluorinated amphetamine analogue that is generally not detected on standard 5-panel, 10-panel, or 12-panel immunoassay drug screens. The fluorine substitution on the phenyl ring alters the molecular structure sufficiently that most amphetamine-targeted antibodies in commercial immunoassays fail to recognize it. However, cross-reactivity varies between manufacturers and assay generations, so a false positive on the amphetamine channel cannot be entirely ruled out.

Urine Detection

Due to the structural similarity to amphetamine, 3-FMA (3-Fluoromethamphetamine) and its metabolites may persist in urine for approximately 2 to 4 days after a single dose. Chronic or heavy use can extend this window. The primary metabolites include deaminated and hydroxylated derivatives, though comprehensive metabolic profiling of 3-FMA (3-Fluoromethamphetamine) in humans remains limited. Standard immunoassay urine cups will typically return a negative result for 3-FMA (3-Fluoromethamphetamine) unless the specific assay has unusually broad cross-reactivity.

Blood and Saliva Detection

3-FMA (3-Fluoromethamphetamine) can be detected in blood and oral fluid for approximately 12 to 48 hours after ingestion. Blood testing is uncommon outside of clinical or forensic contexts. Oral fluid testing follows a similar window but is used primarily in roadside or workplace settings where immediate-use detection is the goal.

Hair Follicle Detection

Hair follicle analysis can theoretically detect 3-FMA (3-Fluoromethamphetamine) for up to 90 days. However, most commercial hair testing laboratories do not include fluorinated amphetamines in their standard panels. Detection requires specific method development using LC-MS/MS with reference standards for 3-FMA (3-Fluoromethamphetamine).

Confirmatory Testing

Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) are the definitive methods for confirming the presence of 3-FMA (3-Fluoromethamphetamine). These techniques can distinguish 3-FMA (3-Fluoromethamphetamine) from amphetamine, methamphetamine, and other substituted amphetamines with high specificity. Reference standards for 3-FMA (3-Fluoromethamphetamine) must be available to the testing laboratory for positive identification.

Reagent Testing

Marquis reagent produces no reaction or a faint orange-brown color with 3-FMA (3-Fluoromethamphetamine), which differs from the orange-to-brown response seen with standard amphetamine. Mecke reagent typically shows no reaction. Simon's reagent can help differentiate primary amines from secondary amines in the amphetamine class. Mandelin reagent may produce a faint green-brown color. These reagent responses help distinguish 3-FMA (3-Fluoromethamphetamine) from MDMA, methamphetamine, and cathinones but cannot confirm identity on their own.

Interactions

Substance	Status	Note
Atropa belladonna	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Datura	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Diphenhydramine	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Harmala alkaloid	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
MAOI	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Myristicin	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Peganum harmala	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
1,3-Butanediol	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1,4-Butanediol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
1B-LSD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1cP-AL-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1cP-LSD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1cP-MiPLA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1P-ETH-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1P-LSD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1V-LSD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2-Aminoindane	Caution	Increased cardiovascular strain and neurotoxicity risk
2-FA	Caution	Increased cardiovascular strain and neurotoxicity risk
2-FEA	Caution	Increased cardiovascular strain and neurotoxicity risk
2-FMA	Caution	Increased cardiovascular strain and neurotoxicity risk
2,5-DMA	Caution	Increased cardiovascular strain and neurotoxicity risk
25B-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25B-NBOMe	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25C-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25C-NBOMe	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25D-NBOMe	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25E-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25I-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25I-NBOMe	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25N-NBOMe	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-B	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-B-FLY	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-C	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-D	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-E	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-H	Caution	Increased cardiovascular strain and neurotoxicity risk
2C-I	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-P	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-2	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-21	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-7	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2M2B	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
3-FA	Caution	Increased cardiovascular strain and neurotoxicity risk
3-FEA	Caution	Increased cardiovascular strain and neurotoxicity risk
3-FPM	Caution	Increased cardiovascular strain and neurotoxicity risk
3-MMC	Caution	Increased cardiovascular strain and neurotoxicity risk
3,4-CTMP	Caution	Increased cardiovascular strain and neurotoxicity risk
3C-E	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
3C-P	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-AcO-DET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-AcO-DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-AcO-DMT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-AcO-MET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-AcO-MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-FA	Caution	Increased cardiovascular strain and neurotoxicity risk
4-FMA	Caution	Increased cardiovascular strain and neurotoxicity risk
4-HO-DET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-DPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-EPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-MET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-MPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-MMC	Caution	Increased cardiovascular strain and neurotoxicity risk
4F-EPH	Caution	Increased cardiovascular strain and neurotoxicity risk
4F-MPH	Caution	Increased cardiovascular strain and neurotoxicity risk
5-APB	Caution	Increased cardiovascular strain and neurotoxicity risk
5-MeO-DALT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
5-MeO-DiBF	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
5-MeO-DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
5-MeO-DMT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
5-MeO-MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
6-APB	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
6-APDB	Caution	Increased cardiovascular strain and neurotoxicity risk
8-Chlorotheophylline	Caution	Increased cardiovascular strain and neurotoxicity risk
A-PHP	Caution	Increased cardiovascular strain and neurotoxicity risk
A-PVP	Caution	Increased cardiovascular strain and neurotoxicity risk
Acetylfentanyl	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Adrafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
AL-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Alcohol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
ALD-52	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Allylescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Alprazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Amphetamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Armodafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
Ayahuasca	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Baclofen	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Benzodiazepines	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Benzydamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Bromantane	Caution	Increased cardiovascular strain and neurotoxicity risk
Bromo-DragonFLY	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Bufotenin	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Buprenorphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Butylone	Caution	Increased cardiovascular strain and neurotoxicity risk
Caffeine	Caution	Increased cardiovascular strain and neurotoxicity risk
Cake	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Carisoprodol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Clonazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Clonazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Clonidine	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Cocaine	Caution	Increased cardiovascular strain and neurotoxicity risk
Codeine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Cyclazodone	Caution	Increased cardiovascular strain and neurotoxicity risk
Deschloroetizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Desomorphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Desoxypipradrol	Caution	Increased cardiovascular strain and neurotoxicity risk
DET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Dextroamphetamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Dextropropoxyphene	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Diazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Dichloropane	Caution	Increased cardiovascular strain and neurotoxicity risk
Diclazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Dihydrocodeine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DMT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOB	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOC	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOI	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOM	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Efavirenz	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Ephedrine	Caution	Increased cardiovascular strain and neurotoxicity risk
Ephylone	Caution	Increased cardiovascular strain and neurotoxicity risk
EPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Escaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Eszopiclone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
ETH-CAT	Caution	Increased cardiovascular strain and neurotoxicity risk
ETH-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Ethylmorphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Ethylone	Caution	Increased cardiovascular strain and neurotoxicity risk
Ethylphenidate	Caution	Increased cardiovascular strain and neurotoxicity risk
Etizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
F-Phenibut	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Fenethylline	Caution	Increased cardiovascular strain and neurotoxicity risk
Fentanyl	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Flualprazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flubromazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flubromazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flunitrazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flunitrazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Gabapentin	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Gaboxadol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
GBL	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
GHB	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Grayanotoxin	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Heroin	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Hexedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Hydrocodone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Hydromorphone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Ibogaine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Isopropylphenidate	Caution	Increased cardiovascular strain and neurotoxicity risk
Kratom	Caution	Increased cardiovascular strain and neurotoxicity risk
LAE-32	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Lisdexamfetamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Lorazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
LSA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
LSD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
LSM-775	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
LSZ	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
MCPP	Caution	Increased cardiovascular strain and neurotoxicity risk
MDA	Caution	Increased cardiovascular strain and neurotoxicity risk
MDMA	Caution	Increased cardiovascular strain and neurotoxicity risk
MDPV	Caution	Increased cardiovascular strain and neurotoxicity risk
Mephedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Mephenaqualone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Mescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
MET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methadone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Methallylescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methamphetamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Methaqualone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Methcathinone	Caution	Increased cardiovascular strain and neurotoxicity risk
Methiopropamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Methylnaphthidate	Caution	Increased cardiovascular strain and neurotoxicity risk
Methylone	Caution	Increased cardiovascular strain and neurotoxicity risk
Methylphenidate	Caution	Increased cardiovascular strain and neurotoxicity risk
Metizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Mexedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Midazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
MiPLA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Mirtazapine	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Modafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
Morphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
MPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
N-Ethylhexedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
N-Methylbisfluoromodafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
Naloxone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
NEP	Caution	Increased cardiovascular strain and neurotoxicity risk
Nicotine	Caution	Increased cardiovascular strain and neurotoxicity risk
Nifoxipam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
NM-2-AI	Caution	Increased cardiovascular strain and neurotoxicity risk
O-Desmethyltramadol	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Oxiracetam	Caution	Increased cardiovascular strain and neurotoxicity risk
Oxycodone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Oxymorphone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
PARGY-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Pentedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Pentobarbital	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Pethidine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Phenobarbital	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Phenylpiracetam	Caution	Increased cardiovascular strain and neurotoxicity risk
PRO-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Psilocybin Mushrooms	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increased cardiovascular strain and neurotoxicity risk
SAMe	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other

Toxicity & Safety

Overview

The toxicity of 3-FMA has not been formally studied. As a presumed triple releasing agent with serotonergic activity, it carries a risk profile that includes both the cardiovascular risks of stimulants and the potential neurotoxic and serotonin syndrome risks of serotonergic agents.

Serotonergic Neurotoxicity

The key toxicological concern distinguishing 3-FMA from purely dopaminergic stimulants is its potential serotonergic neurotoxicity. Compounds that cause sustained, high-magnitude serotonin release — such as MDMA — are associated with neurotoxic damage to serotonergic axon terminals at high doses or with frequent heavy use. The degree to which 3-FMA shares this risk is unknown, but the risk cannot be dismissed.

Serotonin Syndrome Risk

The serotonin releasing activity of 3-FMA creates meaningful risk of serotonin syndrome when combined with other serotonergic substances — SSRIs, SNRIs, MAOIs, other serotonergic entactogens, tramadol, or lithium. This represents an important drug interaction hazard.

Cardiovascular Risk

Standard sympathomimetic cardiovascular risks apply: elevated heart rate, blood pressure, risk of arrhythmia with heavy use.

Comedown Profile

The serotonergic component produces more significant comedowns than purely dopaminergic stimulants. Community experience reports include the familiar post-entactogen "comedown" of low mood, fatigue, and difficulty feeling pleasure for 1–3 days following use — analogous to a mild version of the MDMA comedown.

Overdose Information

Stimulant overdose from 3-FMA is a medical emergency primarily involving cardiovascular and neurological toxicity.

Signs of overdose: Extremely rapid or irregular heartbeat, chest pain, severe headache, dangerously elevated body temperature, seizures, agitation progressing to psychosis, confusion, and loss of consciousness.

Emergency response:

Call emergency services immediately
Keep the person cool (remove excess clothing, apply cool water)
If seizures occur, protect the head and clear the area of hard objects
If the person loses consciousness, place in recovery position
Do not give the person more stimulants, caffeine, or depressants unless directed by medical professionals

Prevention: Pre-measure doses. Avoid redosing. Stay hydrated (but don't overhydrate). Take breaks from physical activity. Monitor heart rate if possible. Have someone present who can recognize warning signs.

Full	Unknown
Half	Unknown
Zero	Unknown

3-FMA

Quick Dosage

Dosage

oral

Duration

oral

How It Feels

Subjective Effects

Physical Effects

Physical(1)

Cognitive & Perceptual Effects

Cognitive(4)

Pharmacology

Mechanism of Action

Receptor Profile

Pharmacokinetics

Comparison with Related Compounds

Detection Methods

Standard Drug Panel Inclusion

Urine Detection

Blood and Saliva Detection

Hair Follicle Detection

Confirmatory Testing

Reagent Testing

Interactions

History

Development Context

Position in the Market

Regulatory Status

Harm Reduction

Treat as a Partial Entactogen

Critical Drug Interactions

Dose and Duration Guidance

Allow Recovery Time

Toxicity & Safety

Overview

Serotonergic Neurotoxicity

Serotonin Syndrome Risk

Cardiovascular Risk

Comedown Profile

Overdose Information

Dangerous Interactions

Tolerance

Legal Status

Experience Reports (2)

Tips (3)

See Also

References (4)

Frequently Asked Questions